TherapyEscalationFollowinganElevated HbA 1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis
TherapyEscalationFollowinganElevated HbA 1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis
复制标题
澳大利亚 45 岁及以上糖尿病患者 HbA 1c 升高后的治疗升级：真实世界观察分析
DOI：
10.2337/dc20-0269
复制
发表时间：
2020
期刊：
影响因子：
16.2
通讯作者：
Carinna Hockham
中科院分区：
文献类型：
--
作者：
Ying Xie;Jannah Baker;Tamara Young;Min Jun;Louisa Sukkar;Anna Campain;Amy Kang;Alan Cass;Ji Hu;David Peiris;Carol Pollock;Germaine Wong;Sophia Zoungas;Kris Rogers;Meg Jardine;Carinna Hockham
降糖治疗逐步升级为强化治疗是2型糖尿病管理不可或缺的组成部分（1）。早期血糖控制与长期微血管和大血管结局的有益影响相关（2）。了解糖化血红蛋白（HbA 1c）升高后治疗时间增加的相关因素可能有助于及时控制。我们使用关联的真实世界数据来检查记录的HbA 1c <8.0%（64 mmol/mol）和相关因素后的治疗时间递增。以便于及时控制。我们使用相关的真实世界数据来检查记录的HbA 1c <8.0%（64 mmol/mol）后治疗时间的增加和相关因素。
Stepwise escalation of glucose-lowering therapytomoreintensiveregimensisan integral component of type 2 diabetes management (1). Early blood glucose.control is associated with beneficial effects on long-term micro- and macro-vascular outcomes (2). Understanding factors associated with time to therapy.escalationfollowinganelevatedglycated hemoglobin (HbA 1c ) may inform interventions to facilitate timely control. We used linked real-world data to examine.time to therapy escalation following a recorded HbA 1c $8.0% (64 mmol/mol) nd associated factors...ventions to facilitate timely control. We.used linked real-world data to examine.time to therapy escalation following a.recorded HbA 1c $8.0% (64 mmol/mol).and associated factors.